Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Aroa Biosurgery Ltd

ARX.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Medical Equipment, Supplies & Distribution ·

Australia Micro Cap Analyst: BUY

Last Close

$0.42

▲ +1.69%

Market Cap $146.40M · Vol 360.40K

Key Metrics

P/E Ratio

60.89

FWD: 40.13

Market Cap

$146.40M

Micro Cap

Div Yield

N/A

EPS Growth

-16.73%

YoY

RSI (14)

54.76

Momentum

Beta

1.58

vs Market

52W High

$0.57

19.33% below

52W Low

$0.35

19.74% above

Volume

360.40K

Avg 386.06K

P/B

2.49

Price-to-book

ROE

6.53%

Return on equity

Free Float

72.71%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Aroa Biosurgery Ltd (ARX.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ARX.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+7.14%

+0.84%

-3.23%

-14.89%

YTD

-18.92%

-4.76%

-26.03%

-44.95%

Financials & Valuation

TTM · Annual

Total Revenue	$59.66M
Net Income	$2.69M
Revenue Growth (YoY)	+29.54%
Gross Margin	85.53%
Operating Margin	4.83%
Net Profit Margin	4.50%
ROE	6.53%
ROA · ROIC	4.59% · 5.06%

P/E Ratio	60.89
Forward P/E (FY1)	40.13
PEG Ratio	0.26
P/S	2.50
P/B	2.49
P/FCF	40.96
EPS Growth	-16.73%
Outstanding Shares	345.90M

Technical Indicators

50-Day SMA	$0.42
200-Day SMA	$0.45
RSI (14)	54.76
Beta	1.58
52-Week High	$0.57
52-Week Low	$0.35

Volume Today	360.40K
Avg Daily Volume (30D)	386.06K
Relative Volume	0.93x
Volatility (10D)	49.70
Volatility (30D)	51.44
Free Float	72.71%

Analyst Consensus

BUY

Current Price $0.42

Mean Target $0.77

52W Low$0.35 52W High$0.57

Current

Target

$0.35 $0.57

Current Analyst target

+80.50% upside potential · 3 analysts

Identifiers

ExchangeASX

FIGIBBG00VX929W8

ISINNZARXE0001S1

CountryNew Zealand

Sub-IndustryMedical Supplies

Earnings DateAug 25, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

COLO B.CO Coloplast A/S -0.49% 603301.SS Zhende Medical Co Ltd -0.78% 300888.SZ Winner Medical Co Ltd -0.92% 1066.HK Shandong Weigao Group Medical Polymer Co Ltd -1.44% 300529.SZ Jafron Biomedical Co Ltd -0.98%

Company Profile

Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from the ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that serve as the building blocks for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, Symphony, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM designed for soft tissue repair, reinforcement, and complex wounds.